Wayne Hawthorne is Senior Research Fellow in Surgery within the faculty of Medicine at the University of Sydney. He is also Director of National Pancreas and Islet Transplant Laboratories at Westmead Hospital.
Dr Hawthorne's main research interest is in clinical islet transplantation and is the director of the islet isolation core for the JDRF/NH&MRC program grant for the Australian wide islet transplantation consortium. The aim of which is the development of pancreatic islet transplantation as a mainstream therapy for patients with difficult to control Type 1 diabetes.
His laboratory research is focused primarily on the surgical models used for assessment of immunobiology of islet xenograft rejection and developing islet xenografts as a clinical therapy. His major focus rests on the joint NHMRC/JDRF program grant that is devoted to the development of pig islets as treatment for patients suffering from Type 1 diabetes.
He has long-standing collaborations with researchers within Australia at, St Vincent's Hospital Melbourne, Walter and Eliza Hall Institute, The Garvan Institute, Adelaide University, The Children's Hospital at Westmead and overseas at the Diabetes Institute for Immunology and Transplantation, Minneapolis University, Minneapolis, USA, Edmonton Clinical Islet Transplant Unit, Edmonton, Canada, National Human Stem Cells Research Engineering Center of the Hunan Province and the Cell Transplantation and Gene Therapy Research Centers of China.
|
|
 Anna deFazio is Senior Clinical Lecturer, Department of Obstetrics and Gynaecology, University of Sydney and the Head of the Gynaecological Oncology Research Group, Westmead Institute for Cancer Research at Westmead Hospital.
She embarked on postdoctoral studies at the Garvan Institute of Medical Research in Sydney (1988-1995) and moved to the Department of Gynaecological Oncology at Westmead Hospital in 1995. Dr deFazio was appointed a Senior Clinical Lecturer of the University of Sydney in 1999.
Dr deFazio has a long-standing commitment to translational research with an emphasis on gynaecological malignancies. Her research program is focused on improving treatment outcome, particularly for women with ovarian cancer, and on identifying factors that modify risk of developing cancer.
She works with a team of postdoctoral researchers, postgraduate students, research assistants and clinical colleagues, and has active collaborations with other local, national and international research groups. The group is supported by national and international peer-reviewed grants.
 |
Click here to view the Ovarian Cancer Fact Sheet (PDF, 139Kb). |
|
WMI Researchers are part of the teams to receive NHMRC Enabling Grants over the next five years which will assist with the Australiasian Biospecimen Network and Breast Cancer Biospecimen Resource. 
